{"tm":1686889006,"s":"BIIB","news":[{"t":"ISS backs election of Langer to replace former Biogen director Denner","dt":"Jun-15-23 02:32PM","a":"Reuters","u":"https:\/\/finance.yahoo.com\/news\/iss-backs-election-langer-replace-183217751.html"},{"t":"Biotech Stock Roundup: KDNY Up on NVS Buyout, BIIB &amp; Eisai's AD Drug Update &amp; More","dt":"10:21AM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/biotech-stock-roundup-kdny-nvs-142100651.html"},{"t":"Markets Rise Midday as Inflation News Raises Expectations of a Rate Hike Pause","dt":"12:20PM","a":"Investopedia","u":"https:\/\/finance.yahoo.com\/m\/7f535b52-cde1-351f-b66f-38fb20442cea\/markets-rise-midday-as.html"},{"t":"FOCUS-European Alzheimer's experts unconvinced by new Eisai, Biogen drug","dt":"03:00AM","a":"Reuters","u":"https:\/\/finance.yahoo.com\/news\/focus-european-alzheimers-experts-unconvinced-070000434.html"},{"t":"These Stocks Are Moving the Most Today: Tesla, Carnival, Nasdaq, SoFi, and More","dt":"01:24PM","a":"Barrons.com","u":"https:\/\/finance.yahoo.com\/m\/e52ff48c-23f0-3f15-9c1e-c5d78aa8736c\/these-stocks-are-moving-the.html"},{"t":"FDA recommends Biogen's Alzheimer's drug for approval","dt":"09:58AM","a":"Yahoo Finance Video","u":"https:\/\/finance.yahoo.com\/video\/fda-recommends-biogens-alzheimers-drug-135841409.html"},{"t":"Stocks to Watch Monday: Biogen, Illumina, Oracle","dt":"08:13AM","a":"The Wall Street Journal","u":"https:\/\/finance.yahoo.com\/m\/39f7624c-855e-357c-9d83-3f01a7bbbb99\/stocks-to-watch-monday%3A.html"},{"t":"Biogen rises as FDA panel backs Alzheimer's drug, easing safety concerns","dt":"06:26AM","a":"Reuters","u":"https:\/\/finance.yahoo.com\/news\/biogen-rises-fda-panel-backs-102614026.html"},{"t":"Biogen shares jump after FDA advisory panel backs Alzheimer's drug","dt":"02:54AM","a":"Investing.com","u":"https:\/\/finance.yahoo.com\/news\/biogen-shares-jump-fda-advisory-065401937.html"},{"t":"FDA Advisory Committee Votes in Favor of Biogen Alzheimers Drug, Clears Path to Full Approval","dt":"05:18PM","a":"Barrons.com","u":"https:\/\/finance.yahoo.com\/m\/1cf2858a-b6ba-3f37-b0fc-aa0e79940252\/fda-advisory-committee-votes.html"},{"t":"US FDA panel back traditional approval for Eisai-Biogen's Alzheimer's drug Leqembi","dt":"03:50PM","a":"Reuters","u":"https:\/\/finance.yahoo.com\/news\/us-fda-panel-back-traditional-195003201.html"},{"t":"UPDATE 5-US FDA panel backs approval for Eisai-Biogen Alzheimer's drug Leqembi","dt":"10:50AM","a":"Reuters","u":"https:\/\/finance.yahoo.com\/news\/1-fda-panel-weighs-us-145038843.html"},{"t":"Biogen Takes Alzheimers Drug to FDA Advisers. The Last Time Was a Disaster.","dt":"02:00AM","a":"Barrons.com","u":"https:\/\/finance.yahoo.com\/m\/1cf2858a-b6ba-3f37-b0fc-aa0e79940252\/biogen-takes-alzheimer%E2%80%99s-drug.html"},{"t":"Biotech Stock Roundup: GSK Provides Updates, Biogen to Discontinue Study &amp; More","dt":"12:38PM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/biotech-stock-roundup-gsk-provides-163800724.html"},{"t":"Mastering the Double-Bottom Pattern (Unveiling 3 Intriguing Setups in Today's Market)","dt":"06:14PM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/mastering-double-bottom-pattern-unveiling-221400203.html"},{"t":"FDA staff say Eisai's Alzheimer's drug may get full approval despite concerns","dt":"11:06AM","a":"Reuters","u":"https:\/\/finance.yahoo.com\/news\/fda-staff-eisais-alzheimers-drug-150635815.html"},{"t":"Biogen (BIIB) to End One of Two Parkinson's Studies on BIIB122","dt":"Jun-06-23 10:58AM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/biogen-biib-end-one-two-145800652.html"},{"t":"Ionis (IONS) Posts Two-Year Upbeat Data From HAE Drug Study","dt":"Jun-02-23 12:35PM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/ionis-ions-posts-two-upbeat-163500848.html"},{"t":"Medicare Will Pay for Biogens Alzheimers Drug, With a Caveat","dt":"12:09PM","a":"Barrons.com","u":"https:\/\/finance.yahoo.com\/m\/5822e1ca-3511-387f-855f-27663d9d5c39\/medicare-will-pay-for.html"},{"t":"Biogen Inc. (NASDAQ:BIIB) is favoured by institutional owners who hold 88% of the company","dt":"May-29-23 10:00AM","a":"Simply Wall St.","u":"https:\/\/finance.yahoo.com\/news\/biogen-inc-nasdaq-biib-favoured-140016083.html"},{"t":"14 Best Biotech Stocks To Buy According To Hedge Funds","dt":"04:03AM","a":"Insider Monkey","u":"https:\/\/finance.yahoo.com\/news\/14-best-biotech-stocks-buy-080352111.html"},{"t":"1 Major Advantage Biogen May Have Over Pharma Giant Eli Lilly in a Multibillion-Dollar Market","dt":"08:15AM","a":"Motley Fool","u":"https:\/\/finance.yahoo.com\/m\/fff42f6a-26bd-3afd-b394-5c941c03614c\/1-major-advantage-biogen-may.html"},{"t":"Health Canada Accepts New Drug Submission for Lecanemab as Treatment for Early Alzheimers Disease","dt":"May-15-23 07:30PM","a":"GlobeNewswire","u":"https:\/\/finance.yahoo.com\/news\/health-canada-accepts-drug-submission-233000988.html"},{"t":"3 Reasons to Buy Biogen Stock (and 1 to Sell)","dt":"May-12-23 10:15AM","a":"Motley Fool","u":"https:\/\/finance.yahoo.com\/m\/e9c3e08f-289f-3eb8-8d5d-34ec220d7d9b\/3-reasons-to-buy-biogen-stock.html"},{"t":"Biogen's (NASDAQ:BIIB) investors will be pleased with their favorable 64% return over the last year","dt":"08:00AM","a":"Simply Wall St.","u":"https:\/\/finance.yahoo.com\/news\/biogens-nasdaq-biib-investors-pleased-120027676.html"},{"t":"15 Biggest Immunotherapy Companies in the World","dt":"May-09-23 04:09PM","a":"Insider Monkey","u":"https:\/\/finance.yahoo.com\/news\/15-biggest-immunotherapy-companies-world-200959863.html"},{"t":"Two Alzheimers drugs offer hope to patients after decades of waiting","dt":"12:00AM","a":"Financial Times","u":"https:\/\/finance.yahoo.com\/m\/2933a8f9-d691-38c1-a196-402161c23c32\/two-alzheimer%E2%80%99s-drugs-offer.html"},{"t":"Q1 2023 Ionis Pharmaceuticals Inc Earnings Call","dt":"04:10AM","a":"Thomson Reuters StreetEvents","u":"https:\/\/finance.yahoo.com\/news\/q1-2023-ionis-pharmaceuticals-inc-081004541.html"},{"t":"Eli Lilly Hits A Record-Smashing $409 Billion Market Cap Following Its Alzheimer's Win","dt":"04:05PM","a":"Investor's Business Daily","u":"https:\/\/finance.yahoo.com\/m\/6420e4cc-dce1-3d26-a322-77d33fdc2f02\/eli-lilly-hits-a.html"},{"t":"Eli Lilly Surges After Alzheimer's Treatment Succeeds; Biogen Also Rises","dt":"09:16AM","a":"Investor's Business Daily","u":"https:\/\/finance.yahoo.com\/m\/6420e4cc-dce1-3d26-a322-77d33fdc2f02\/eli-lilly-surges-after.html"},{"t":"Weekly Stock List","dt":"May-01-23 08:00AM","a":"Argus Research","u":"https:\/\/finance.yahoo.com\/m\/24c7c33e-5b42-3802-a5dc-ac2f269f5854\/weekly-stock-list.html"},{"t":"The 3\u00a0Most Promising Biotech Innovations in 2023 and the Stocks to Buy","dt":"06:26AM","a":"InvestorPlace","u":"https:\/\/finance.yahoo.com\/news\/3-most-promising-biotech-innovations-102631625.html"},{"t":"Biogen's Amyotrophic Lateral Sclerosis Drug Scores Conditional Approval From FDA","dt":"Apr-26-23 01:53PM","a":"Benzinga","u":"https:\/\/finance.yahoo.com\/news\/biogens-amyotrophic-lateral-sclerosis-drug-175320362.html"}]}